With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
You can get a huge one according to this economic analysis in terms of price per year of life saved when CAR T-cells are used on pediatric patients, who have a 40% chance of cure at potentially very young ages all in contrast to adults. You do the math. | Whittington, JAMA Pediat 2017